Euroopa farmakopöaga seoses

1

Signe Leito

Saatja: [email protected] Saatmisaeg: kolmapäev, 25. juuni 2025 18:47 Adressaat: Signe Leito Teema: Proposed suppression of the monograph Pivampicillin (0852) from the WP of Group 7: EDQM-2025-02746-mail

Please make sure to include in any reply our mail reference: EDQM-2025-02746-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues,

Please find below the link to a survey being carried out concerning the proposed suppression of the monograph Pivampicillin (0852) from the European Pharmacopoeia of Group 7.

In order to have access to the survey, please copy and paste this link into your Internet browser:

https://survey.edqm.eu/index.php?r=survey/index&sid=178777&lang=en

Deadline for replies: 12 September 2025.

Thank you very much in advance.

With kind regards

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.

2

On behalf of Matthieu ANTONI

---------- Rachel HEGENHAUSER Assistant - European Pharmacopoeia Department EDQM - Council of Europe 7 Allee Kastner Cs-30026 F-67081 Strasbourg France [email protected] www.edqm.eu **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-02746-mail